Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-inflammatory effects of 4,4'-diaminodiphenyl sulfone (dapsone) in lipopolysaccharide-treated spleen cells: selective inhibition of inflammation-related cytokines

지질다당류를 투여한 비장세포에서 4,4'-diaminodiphenyl sulfone (dapsone)의 항염증 효과: 염증 관련 사이토카인의 선택적 억제

  • Moon, Sun-Young (Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Jeju National University) ;
  • Joo, Hong-Gu (Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Jeju National University)
  • 문선영 (제주대학교 수의과대학 수의약리학실) ;
  • 주홍구 (제주대학교 수의과대학 수의약리학실)
  • Received : 2015.06.10
  • Accepted : 2015.07.28
  • Published : 2015.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

4,4'-diaminodiphenyl sulfone (dapsone) is a sulfone drug that has antibacterial effects on a variety of bacteria, especially Mycobacterium leprae; thus, it has been used to treat leprosy. Previous studies demonstrated that dapsone inhibits integrin-mediated adherence of neutrophils and production of prostaglandin $E_2$ by polymorphonuclear leukocytes. Hence, dapsone may act in immune cells and regulate cell-mediated inflammation processes. However, its anti-inflammatory effects remain unclear. The present study demonstrated that dapsone modulates the production of inflammation-related cytokines in immune cells. We employed the spleen cells of mice, which are major immune cells, and lipopolysaccharide (LPS) as a causative agent of inflammation for experiments. Dapsone induced a proportional change in splenocyte subsets and the apoptosis of spleen cells. Interestingly, dapsone decreased the production of tumor necrosis factor-alpha and interleukin (IL)-10, but not IL-6, in LPS-treated spleen cells. In other assays, we measured the dapsone-induced production of nitric oxide (NO) and the expression of activation markers of spleen cells. Dapsone decreased NO production in LPS-treated spleen cells. Taken together, our results demonstrate that dapsone has anti-inflammatory effects in immune cells and provide new insight into the potential uses of this agent.

Keywords

References

  1. Anderson R. Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro. Antimicrob Agents Chemother 1985, 27, 257-262. https://doi.org/10.1128/AAC.27.2.257
  2. Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992, 98, 135-140. https://doi.org/10.1111/1523-1747.ep12555654
  3. Chakravortty D, Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 2003, 5, 621-627. https://doi.org/10.1016/S1286-4579(03)00096-0
  4. Coleman MD. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology 2001, 162, 53-60. https://doi.org/10.1016/S0300-483X(01)00360-2
  5. Croft M, Duan W, Choi H, Eun SY, Madireddi S, Mehta A. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 2012, 33, 144-152. https://doi.org/10.1016/j.it.2011.10.004
  6. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a ${\beta}$-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001, 69, 555-564.
  7. Kim MH, Byon YY, Ko EJ, Song JY, Yun YS, Shin T, Joo HG. Immunomodulatory activity of ginsan, a polysaccharide of Panax ginseng, on dendritic cells. Korean J Physiol Pharmacol 2009, 13, 169-173. https://doi.org/10.4196/kjpp.2009.13.3.169
  8. Kountouras J, Zavos C, Chatzopoulos D. Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med 2004, 8, 317-328. https://doi.org/10.1111/j.1582-4934.2004.tb00321.x
  9. Marzio R, Mauël J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 1999, 21, 565-582. https://doi.org/10.3109/08923979909007126
  10. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000, 117, 1162-1172. https://doi.org/10.1378/chest.117.4.1162
  11. Plotnikova N, Miller JL. Dermatitis herpetiformis. Skin Therapy Lett 2013, 18, 1-3.
  12. Ramos-e-Silva M, Rebello PFB. Leprosy. Recognition and treatment. Am J Clin Dermatol 2001, 2, 203-211. https://doi.org/10.2165/00128071-200102040-00001
  13. Rincon M. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 2012, 33, 571-577. https://doi.org/10.1016/j.it.2012.07.003
  14. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. Biology of interleukin-10. Cytokine Growth Factor Rev 2010, 21, 331-344. https://doi.org/10.1016/j.cytogfr.2010.09.002
  15. Shipkova M, Wieland E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta 2012, 413, 1338-1349. https://doi.org/10.1016/j.cca.2011.11.006
  16. Van Zyl JM, Basson K, Kriegler A, van der Walt BJ. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system: a possible correlation with their anti-inflammatory properties. Biochem Pharmacol 1991, 42, 599-608. https://doi.org/10.1016/0006-2952(91)90323-W
  17. Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014, 306, 103-124. https://doi.org/10.1007/s00403-013-1409-7

Cited by

  1. Fermented antler extract enhances the viability and interleukin-12 production of spleen cells vol.56, pp.3, 2016, https://doi.org/10.14405/kjvr.2016.56.3.183
  2. Lipopolysaccharide에 의해 과활성화된 마우스 비장세포에서 Enrofloxacin의 조절작용 vol.59, pp.2, 2019, https://doi.org/10.14405/kjvr.2019.59.2.75
  3. HL-60세포에서 disulfiram의 항암작용과 미토콘드리아 안정성에 대한 연구 vol.59, pp.4, 2015, https://doi.org/10.14405/kjvr.2019.59.4.195
  4. Fenbendazole의 항암활성에서 활성산소종의 관련성 vol.60, pp.2, 2015, https://doi.org/10.14405/kjvr.2020.60.2.79